Sandoz, a Novartis division, a …
Read News ArticleCategory: Latest News
Bloomberg Senior Executive Editor Among Honorees at National Annual Benefit
John McCorry, Senior Executive …
Read News ArticleFDA Grants Gilenya® Breakthrough Therapy Designation for Pediatric MS
On December 18, 2017, Novartis …
Read News ArticleHighlights from the 2017 Joint ECTRIMS-ACTRIMS Meeting
MSParis2017 was this year’s jo …
Read News ArticleNew Publications to Manage Multiple Sclerosis from MSAA
Free Publications Providing Ex …
Read News ArticleMSAA Expands MRI Assistance and Helpline Hours
To help meet the escalating de …
Read News ArticleFDA Approves Two Doses of Generic Copaxone for MS
On October 4, 2017, Mylan anno …
Read News ArticleMSAA’s Mobile Phone App, My MS Manager™, Named One of the Best MS Apps of 2017 by Healthline
The Multiple Sclerosis Associa …
Read News ArticleMSAA’s Magazine, The Motivator, Wins 2017 National Health Information Award
The Multiple Sclerosis Associa …
Read News ArticleHighlights from the AAN and CMSC 2017 Annual Meetings
During the past few decades, a …
Read News Article